Market News
Wednesday, December 21, 2016
Inovio's Zika vaccine evokes robust response in human study
Dec 21 (Reuters) - Inovio Pharmaceuticals Inc said
its experimental Zika vaccine induced robust immune responses in
an early-stage study in human volunteers who have not been
infected with the virus.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment